Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash from Investing Activities (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Cash from Investing Activities data on record, last reported at -$116000.0 in Q1 2013.

  • For Q1 2013, Cash from Investing Activities rose 14.07% year-over-year to -$116000.0; the TTM value through Mar 2013 reached -$370000.0, down 2.78%, while the annual FY2025 figure was -$80000.0, 3900.0% down from the prior year.
  • Cash from Investing Activities reached -$116000.0 in Q1 2013 per SNOA's latest filing, down from -$49000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$10000.0 in Q4 2010 and bottomed at -$172000.0 in Q3 2012.
  • Average Cash from Investing Activities over 4 years is -$74500.0, with a median of -$64500.0 recorded in 2011.
  • Peak YoY movement for Cash from Investing Activities: plummeted 410.0% in 2011, then surged 57.69% in 2012.
  • A 4-year view of Cash from Investing Activities shows it stood at -$10000.0 in 2010, then tumbled by 410.0% to -$51000.0 in 2011, then rose by 3.92% to -$49000.0 in 2012, then crashed by 136.73% to -$116000.0 in 2013.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$116000.0 in Q1 2013, -$49000.0 in Q4 2012, and -$172000.0 in Q3 2012.